Trial Profile
Marinobufagenin as a Target for DIGIBIND in Preeclampsia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Anti-digoxin polyclonal antibody (Primary)
- Indications Preeclampsia
- Focus Pharmacodynamics; Proof of concept
- 25 Mar 2012 New trial record